Veradermics (MANE) Q1 2026 Earnings
MANE·Reported May 12, 2026·Before market open
Diluted EPS came in at $-1.32, missed the $-0.56 consensus by $0.76.
Diluted EPS
$-1.32missed by $0.76
Consensus: $-0.56
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Veradermics 's Q1 2026 earnings report.
Veradermics (MANE) reported Q1 2026 earnings on May 12, 2026 before market open.
Veradermics reported diluted EPS of $-1.32 for Q1 2026.
EPS missed the consensus estimate of $-0.56 by $0.76.
You can read the 8-K earnings release (0001827635-26-000016) and the 10-Q periodic report (0001827635-26-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.